Hepatology
From the Journals
AVERT: Apixaban reduced thromboembolism risk in cancer patients
Cancer patients treated with apixaban had a significantly lower rate of venous thromboembolism but a higher risk of major bleeds than did those...
Conference Coverage
Daily hydroxyurea effective, safe for African children
SAN DIEGO – Hydroxyurea was associated with reduced rates of malaria and in other infections, resulting in improved survival.
Conference Coverage
Early treatment with direct-acting antivirals linked to reduced medical costs in noncirrhotic HCV
Conference Coverage
Skin rashes often accompany drug-induced liver injury
SAN FRANCISCO – A survey of drug-induced liver and skin injuries finds they often co-occur and identifies some classes of drugs associated with...
Conference Coverage
High rates of HCV treatment completion seen in people who inject drugs
Treatment of people who inject drugs will help prevent new cases of HCV, study coauthor maintains.
Conference Coverage
Risk of cancer in NAFLD is 91% higher than in control subjects
SAN FRANCISCO – The observed increase is highest in gastrointestinal cancer subjects.
Conference Coverage
Chronic liver disease independently linked to increased risk of falls
SAN FRANCISCO – Subjects with viral hepatitis had the strongest association with a history of falls.
Conference Coverage
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
SAN FRANCISCO – Nearly one-quarter were receiving substantial high-dose opioid prescriptions.
Latest News
Good news, bad news about HCV in kidney disease
While new drugs wipe out the virus, outbreaks are still hitting dialysis clinics.
From the Journals
Reviewing the state of HCV and HBV in children
Conference Coverage
ACIP votes unanimously in favor of immunization schedule update and redesign